Vanguard Global Advisers
CLMT icon

Vanguard Global Advisers’s Calumet Specialty Products CLMT Stock Holding History

Vanguard Global Advisers’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Sell
32,457
-1,635
-5% -$55K ﹤0.01% 1650
2026
Q1 		$1.22M Buy
+34,092
New +$883K ﹤0.01% 1512

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Global Advisers's CLMT Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Calumet Specialty Products (CLMT) stake by 4.8% in Q2 2026, selling an estimated $55K and leaving 32,457 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1650.

Vanguard Global Advisers first reported a position in CLMT in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.22M in Q1 2026. 186 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Vanguard Global Advisers held 32,457 shares of Calumet Specialty Products worth $1.17M as of Q2 2026.
  • Vanguard Global Advisers sold 1,635 Calumet Specialty Products shares in Q2 2026, an estimated $55K.
  • Calumet Specialty Products made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1650 holding.
  • Vanguard Global Advisers first reported a position in Calumet Specialty Products in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Calumet Specialty Products position peaked at $1.22M in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.